News
Hemostemix's presentation at TERMIS 2025 reflects its commitment to innovation, evidence-based clinical research, and advancing ACP-01 as a new standard of care for patients suffering from peripheral ...
Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in tissue-targeted AAV gene therapy, today announces the ...
Event: H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq Location: Nasdaq World Headquarters, New York, NY Fireside Chat: Tuesday, May 20, 12:30 p.m. EST Webcast: ...
Researchers have developed a novel technology that allows the distribution of components within a single cell to be accurately detected and visualized. Positioning a t-SPESI (tapping-mode scanning ...
21h
Talker on MSNNew generation of skin substitutes give hope to severe burn patientsResearchers have flagged some "promising" new approaches that could save lives and dramatically improve patient recovery. The ...
Discover why Genmab's antibody platforms, growing royalties, and late-stage pipeline make it a top biotech stock for ...
University of California, Los Angeles and University of California, San Diego researchers developed an injectable sealant for ...
Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...
Placentas contain a rich amount of nutrients and stem cells, but there’s a difference between eating it at home for wellness ...
A Philadelphia entrepreneur developing eye repair tech stood out among international contenders as it gears up to raise a seed round.
Researchers at Kyushu University in Japan have pinpointed the X-linked mutation behind orange fur in house cats.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results